133 related articles for article (PubMed ID: 15316655)
1. Differential effects of monastrol in two human cell lines.
Leizerman I; Avunie-Masala R; Elkabets M; Fich A; Gheber L
Cell Mol Life Sci; 2004 Aug; 61(16):2060-70. PubMed ID: 15316655
[TBL] [Abstract][Full Text] [Related]
2. Mitotic slippage and expression of survivin are linked to differential sensitivity of human cancer cell-lines to the Kinesin-5 inhibitor monastrol.
Asraf H; Avunie-Masala R; Hershfinkel M; Gheber L
PLoS One; 2015; 10(6):e0129255. PubMed ID: 26035434
[TBL] [Abstract][Full Text] [Related]
3. Probing spindle assembly mechanisms with monastrol, a small molecule inhibitor of the mitotic kinesin, Eg5.
Kapoor TM; Mayer TU; Coughlin ML; Mitchison TJ
J Cell Biol; 2000 Sep; 150(5):975-88. PubMed ID: 10973989
[TBL] [Abstract][Full Text] [Related]
4. Induction of apoptosis by monastrol, an inhibitor of the mitotic kinesin Eg5, is independent of the spindle checkpoint.
Chin GM; Herbst R
Mol Cancer Ther; 2006 Oct; 5(10):2580-91. PubMed ID: 17041103
[TBL] [Abstract][Full Text] [Related]
5. Kinesin-5 motors are required for organization of spindle microtubules in Silvetia compressa zygotes.
Peters NT; Kropf DL
BMC Plant Biol; 2006 Aug; 6():19. PubMed ID: 16945151
[TBL] [Abstract][Full Text] [Related]
6. Interaction of the mitotic kinesin Eg5 inhibitor monastrol with P-glycoprotein.
Peters T; Lindenmaier H; Haefeli WE; Weiss J
Naunyn Schmiedebergs Arch Pharmacol; 2006 Jan; 372(4):291-9. PubMed ID: 16365780
[TBL] [Abstract][Full Text] [Related]
7. Interaction of the mitotic inhibitor monastrol with human kinesin Eg5.
DeBonis S; Simorre JP; Crevel I; Lebeau L; Skoufias DA; Blangy A; Ebel C; Gans P; Cross R; Hackney DD; Wade RH; Kozielski F
Biochemistry; 2003 Jan; 42(2):338-49. PubMed ID: 12525161
[TBL] [Abstract][Full Text] [Related]
8. NSC 622124 inhibits human Eg5 and other kinesins via interaction with the conserved microtubule-binding site.
Learman SS; Kim CD; Stevens NS; Kim S; Wojcik EJ; Walker RA
Biochemistry; 2009 Mar; 48(8):1754-62. PubMed ID: 19236100
[TBL] [Abstract][Full Text] [Related]
9. Mechanism of inhibition of human KSP by monastrol: insights from kinetic analysis and the effect of ionic strength on KSP inhibition.
Luo L; Carson JD; Dhanak D; Jackson JR; Huang PS; Lee Y; Sakowicz R; Copeland RA
Biochemistry; 2004 Dec; 43(48):15258-66. PubMed ID: 15568818
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferative activity of monastrol in human adenocarcinoma (MCF-7) and non-tumor (HB4a) breast cells.
Marques LA; Semprebon SC; Niwa AM; D'Epiro GF; Sartori D; de Fátima Â; Ribeiro LR; Mantovani MS
Naunyn Schmiedebergs Arch Pharmacol; 2016 Dec; 389(12):1279-1288. PubMed ID: 27592117
[TBL] [Abstract][Full Text] [Related]
11. Potentiation of kinesin spindle protein inhibitor-induced cell death by modulation of mitochondrial and death receptor apoptotic pathways.
Vijapurkar U; Wang W; Herbst R
Cancer Res; 2007 Jan; 67(1):237-45. PubMed ID: 17210704
[TBL] [Abstract][Full Text] [Related]
12. Impact of the ferrocenyl group on cytotoxicity and KSP inhibitory activity of ferrocenyl monastrol conjugates.
Wieczorek-Błauż A; Kowalczyk K; Błauż A; Makal A; Pawlędzio S; Eurtivong C; Arabshahi HJ; Reynisson J; Hartinger CG; Rychlik B; Plażuk D
Dalton Trans; 2022 Jan; 51(2):491-508. PubMed ID: 34787141
[TBL] [Abstract][Full Text] [Related]
13. Microtubule damaging agents induce apoptosis in HL 60 cells and G2/M cell cycle arrest in HT 29 cells.
Tseng CJ; Wang YJ; Liang YC; Jeng JH; Lee WS; Lin JK; Chen CH; Liu IC; Ho YS
Toxicology; 2002 Jun; 175(1-3):123-42. PubMed ID: 12049842
[TBL] [Abstract][Full Text] [Related]
14. Inhibitors of kinesin Eg5: antiproliferative activity of monastrol analogues against human glioblastoma cells.
Müller C; Gross D; Sarli V; Gartner M; Giannis A; Bernhardt G; Buschauer A
Cancer Chemother Pharmacol; 2007 Feb; 59(2):157-64. PubMed ID: 16703323
[TBL] [Abstract][Full Text] [Related]
15. Evidence that monastrol is an allosteric inhibitor of the mitotic kinesin Eg5.
Maliga Z; Kapoor TM; Mitchison TJ
Chem Biol; 2002 Sep; 9(9):989-96. PubMed ID: 12323373
[TBL] [Abstract][Full Text] [Related]
16. Mechanisms of Taxol-induced cell death are concentration dependent.
Torres K; Horwitz SB
Cancer Res; 1998 Aug; 58(16):3620-6. PubMed ID: 9721870
[TBL] [Abstract][Full Text] [Related]
17. Monastrol inhibition of the mitotic kinesin Eg5.
Cochran JC; Gatial JE; Kapoor TM; Gilbert SP
J Biol Chem; 2005 Apr; 280(13):12658-67. PubMed ID: 15665380
[TBL] [Abstract][Full Text] [Related]
18. Monastrol, a prototype anti-cancer drug that inhibits a mitotic kinesin, induces rapid bursts of axonal outgrowth from cultured postmitotic neurons.
Haque SA; Hasaka TP; Brooks AD; Lobanov PV; Baas PW
Cell Motil Cytoskeleton; 2004 May; 58(1):10-6. PubMed ID: 14983520
[TBL] [Abstract][Full Text] [Related]
19. Expanding the role of HsEg5 within the mitotic and post-mitotic phases of the cell cycle.
Whitehead CM; Rattner JB
J Cell Sci; 1998 Sep; 111 ( Pt 17)():2551-61. PubMed ID: 9701554
[TBL] [Abstract][Full Text] [Related]
20. Monastrol suppresses invasion and metastasis in human colorectal cancer cells by targeting fascin independent of kinesin-Eg5 pathway.
Alburquerque-González B; Montoro-García S; Bernabé-García Á; Bernabé-García M; Campioni-Rodrigues P; Rodríguez-Martínez A; Luque I; Salo T; Pérez-Garrido A; Pérez-Sánchez H; Cayuela ML; Luengo-Gil G; Luchinat E; Postigo-Corrales F; Staderini T; Nicolás FJ; Conesa-Zamora P
Biomed Pharmacother; 2024 Jun; 175():116785. PubMed ID: 38781869
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
